Free Artepharm: Commercialising the Malaria Cure in Africa Case Study Solution | Assignment Help

Harvard Case - Artepharm: Commercialising the Malaria Cure in Africa

"Artepharm: Commercialising the Malaria Cure in Africa" Harvard business case study is written by Hao Liang, Dongning Yang, Han Jiang, Adina Wong. It deals with the challenges in the field of Economics. The case study is 19 page(s) long and it was first published on : Feb 9, 2019

At Fern Fort University, we recommend Artepharm pursue a multi-pronged strategy to commercialize its artemisinin-based malaria treatment in Africa. This strategy should focus on building a robust supply chain, engaging with local governments and communities, and leveraging partnerships to ensure affordability and accessibility.

2. Background

Artepharm, a family-owned Chinese pharmaceutical company, discovered and developed artemisinin, a highly effective antimalarial drug. The company faces the challenge of commercializing this life-saving treatment in Africa, a region heavily burdened by malaria. Artepharm must navigate a complex landscape of poverty, limited healthcare infrastructure, and varying government policies.

The main protagonists in this case study are:

  • Artepharm: A family-owned Chinese pharmaceutical company with a groundbreaking discovery and a desire to make a difference in Africa.
  • African Governments: Facing the challenge of managing malaria outbreaks and seeking affordable solutions.
  • Local Communities: Suffering from the devastating effects of malaria and needing access to effective treatment.
  • International Organizations: Playing a key role in funding and supporting malaria control programs.

3. Analysis of the Case Study

This case study can be analyzed using the following frameworks:

1. Porter's Five Forces:

  • Threat of New Entrants: High, due to the potential for generic drug manufacturers to enter the market.
  • Bargaining Power of Buyers: High, as African governments and international organizations have significant purchasing power and are price-sensitive.
  • Bargaining Power of Suppliers: Low, as the raw materials for artemisinin are readily available.
  • Threat of Substitutes: Moderate, with alternative antimalarial drugs available, albeit less effective.
  • Competitive Rivalry: High, as several pharmaceutical companies are competing in the antimalarial market.

2. Value Chain Analysis:

  • Inbound Logistics: Artepharm needs to establish a robust supply chain in Africa to ensure timely and reliable delivery of its product.
  • Operations: Manufacturing processes must be optimized for cost-effectiveness and quality control.
  • Outbound Logistics: Distribution networks need to reach remote areas and ensure accessibility for all.
  • Marketing and Sales: Effective communication strategies are required to educate healthcare professionals and the public about the benefits of artemisinin.
  • Service: Post-sale support and monitoring are crucial to ensure proper treatment and minimize resistance.

3. PESTLE Analysis:

  • Political: Political instability and corruption can hinder access to healthcare and create challenges for distribution.
  • Economic: Poverty and limited access to healthcare infrastructure make it difficult to reach the most vulnerable populations.
  • Social: Cultural beliefs and practices can influence the acceptance and use of artemisinin.
  • Technological: Innovation in drug delivery and diagnostic tools can improve treatment outcomes.
  • Legal: Government regulations and intellectual property rights need to be carefully navigated.
  • Environmental: Sustainability considerations are important for sourcing raw materials and minimizing environmental impact.

4. Recommendations

Artepharm should adopt a multi-pronged strategy to commercialize artemisinin in Africa:

1. Build a Robust Supply Chain:

  • Establish manufacturing facilities in Africa: This will reduce transportation costs, improve accessibility, and create local jobs.
  • Develop a network of distributors: Partner with local companies to ensure efficient distribution and reach remote areas.
  • Invest in cold chain infrastructure: Ensure the proper storage and transportation of temperature-sensitive medications.

2. Engage with Local Governments and Communities:

  • Negotiate favorable pricing strategies: Work with governments to establish affordable pricing structures that consider the economic realities of the region.
  • Develop public awareness campaigns: Educate communities about malaria prevention, treatment, and the benefits of artemisinin.
  • Collaborate with local NGOs: Partner with NGOs to provide training and support for healthcare workers and community health programs.

3. Leverage Partnerships:

  • Seek funding from international organizations: Secure grants and investments from organizations like the Global Fund to Fight AIDS, Tuberculosis and Malaria.
  • Collaborate with pharmaceutical companies: Partner with other companies to develop innovative drug delivery methods and improve access to treatment.
  • Engage with research institutions: Collaborate with African research institutions to conduct clinical trials and develop new antimalarial drugs.

5. Basis of Recommendations

These recommendations are based on the following considerations:

  • Core Competencies and Consistency with Mission: Artepharm's core competency lies in its expertise in developing and manufacturing antimalarial drugs. These recommendations align with the company's mission to improve global health.
  • External Customers and Internal Clients: The recommendations address the needs of both external customers (governments, healthcare providers, and patients) and internal clients (employees and shareholders).
  • Competitors: The recommendations aim to differentiate Artepharm from competitors by focusing on affordability, accessibility, and social responsibility.
  • Attractiveness ' Quantitative Measures: While quantifying the financial return on investment is challenging due to the complex nature of the market, the recommendations are expected to lead to increased sales, market share, and positive social impact.

6. Conclusion

By implementing these recommendations, Artepharm can effectively commercialize artemisinin in Africa, contributing to the fight against malaria and improving the lives of millions. This strategy will require a long-term commitment to building sustainable partnerships, investing in infrastructure, and engaging with local communities.

7. Discussion

Alternatives:

  • Selling artemisinin at a high price: This would maximize profits but limit access to treatment for the most vulnerable populations.
  • Donating artemisinin: This would ensure accessibility but would not be financially sustainable for Artepharm.

Risks and Key Assumptions:

  • Political instability: Political instability can disrupt supply chains and hinder access to healthcare.
  • Currency fluctuations: Exchange rate fluctuations can impact the profitability of the business.
  • Resistance to artemisinin: The emergence of artemisinin resistance could render the drug ineffective.

8. Next Steps

  • Develop a detailed implementation plan: Outline specific actions, timelines, and resource requirements.
  • Establish a dedicated team: Assemble a team with expertise in international business, healthcare, and development.
  • Conduct pilot programs: Pilot programs in selected countries can test the effectiveness of the strategy and identify areas for improvement.
  • Monitor progress and adapt: Regularly monitor progress against key performance indicators and make adjustments as needed.

By taking these steps, Artepharm can successfully navigate the complex challenges of commercializing its malaria cure in Africa and make a significant contribution to global health.

Hire an expert to write custom solution for HBR Economics case study - Artepharm: Commercialising the Malaria Cure in Africa

Case Description

This case is set January 2019. Song Jianping is senior advisor to Chinese pharmaceutical firm Artepharm, which has been engaging in malaria elimination in Africa since 2003. With a deep understanding of the African market, the company has developed an innovative approach to malaria elimination, stemming from traditional Chinese medicine. It created a combination drug marketed as Artequick and put forward an innovative programme called Fast Elimination of Malaria by Source Eradication (FEMSE). Despite the success of the FEMSE programme, which had been tested in the Comoros and eliminated about 95% of the malaria cases there, Artepharm had been facing a lot of challenges in commercialising its innovative and effective solution. These challenges include a lack of presence in the public market which was dominated by multinational corporations such as Novartis and generic pharmaceutical companies from India. Artepharm recognises that it has realised only a small fraction of the potential sales of antimalarial drugs on the African continent. Song is thinking about the next steps to increase Artequick sales, so that the company can become profitable and not rely on funding from its parent company and the Chinese government.

🎓 Struggling with term papers, essays, or Harvard case studies? Look no further! Fern Fort University offers top-quality, custom-written solutions tailored to your needs. Boost your grades and save time with expertly crafted content. Order now and experience academic excellence! 🌟📚 #MBA #HarvardCaseStudies #CustomEssays #AcademicSuccess #StudySmart Write my custom case study solution for Harvard HBR case - Artepharm: Commercialising the Malaria Cure in Africa

Hire an expert to write custom solution for HBR Economics case study - Artepharm: Commercialising the Malaria Cure in Africa

Artepharm: Commercialising the Malaria Cure in Africa FAQ

What are the qualifications of the writers handling the "Artepharm: Commercialising the Malaria Cure in Africa" case study?

Our writers hold advanced degrees in their respective fields, including MBAs and PhDs from top universities. They have extensive experience in writing and analyzing complex case studies such as " Artepharm: Commercialising the Malaria Cure in Africa ", ensuring high-quality, academically rigorous solutions.

How do you ensure confidentiality and security in handling client information?

We prioritize confidentiality by using secure data encryption, access controls, and strict privacy policies. Apart from an email, we don't collect any information from the client. So there is almost zero risk of breach at our end. Our financial transactions are done by Paypal on their website so all your information is very secure.

What is Fern Fort Univeristy's process for quality control and proofreading in case study solutions?

The Artepharm: Commercialising the Malaria Cure in Africa case study solution undergoes a rigorous quality control process, including multiple rounds of proofreading and editing by experts. We ensure that the content is accurate, well-structured, and free from errors before delivery.

Where can I find free case studies solution for Harvard HBR Strategy Case Studies?

At Fern Fort University provides free case studies solutions for a variety of Harvard HBR case studies. The free solutions are written to build "Wikipedia of case studies on internet". Custom solution services are written based on specific requirements. If free solution helps you with your task then feel free to donate a cup of coffee.

I’m looking for Harvard Business Case Studies Solution for Artepharm: Commercialising the Malaria Cure in Africa. Where can I get it?

You can find the case study solution of the HBR case study "Artepharm: Commercialising the Malaria Cure in Africa" at Fern Fort University.

Can I Buy Case Study Solution for Artepharm: Commercialising the Malaria Cure in Africa & Seek Case Study Help at Fern Fort University?

Yes, you can order your custom case study solution for the Harvard business case - "Artepharm: Commercialising the Malaria Cure in Africa" at Fern Fort University. You can get a comprehensive solution tailored to your requirements.

Can I hire someone only to analyze my Artepharm: Commercialising the Malaria Cure in Africa solution? I have written it, and I want an expert to go through it.

🎓 Struggling with term papers, essays, or Harvard case studies? Look no further! Fern Fort University offers top-quality, custom-written solutions tailored to your needs. Boost your grades and save time with expertly crafted content. Order now and experience academic excellence! 🌟📚 #MBA #HarvardCaseStudies #CustomEssays #AcademicSuccess #StudySmart Pay an expert to write my HBR study solution for the case study - Artepharm: Commercialising the Malaria Cure in Africa

Where can I find a case analysis for Harvard Business School or HBR Cases?

You can find the case study solution of the HBR case study "Artepharm: Commercialising the Malaria Cure in Africa" at Fern Fort University.

Which are some of the all-time best Harvard Review Case Studies?

Some of our all time favorite case studies are -

Can I Pay Someone To Solve My Case Study - "Artepharm: Commercialising the Malaria Cure in Africa"?

Yes, you can pay experts at Fern Fort University to write a custom case study solution that meets all your professional and academic needs.

Do I have to upload case material for the case study Artepharm: Commercialising the Malaria Cure in Africa to buy a custom case study solution?

We recommend to upload your case study because Harvard HBR case studies are updated regularly. So for custom solutions it helps to refer to the same document. The uploading of specific case materials for Artepharm: Commercialising the Malaria Cure in Africa ensures that the custom solution is aligned precisely with your needs. This helps our experts to deliver the most accurate, latest, and relevant solution.

What is a Case Research Method? How can it be applied to the Artepharm: Commercialising the Malaria Cure in Africa case study?

The Case Research Method involves in-depth analysis of a situation, identifying key issues, and proposing strategic solutions. For "Artepharm: Commercialising the Malaria Cure in Africa" case study, this method would be applied by examining the case’s context, challenges, and opportunities to provide a robust solution that aligns with academic rigor.

"I’m Seeking Help with Case Studies,” How can Fern Fort University help me with my case study assignments?

Fern Fort University offers comprehensive case study solutions, including writing, analysis, and consulting services. Whether you need help with strategy formulation, problem-solving, or academic compliance, their experts are equipped to assist with your assignments.

Achieve academic excellence with Fern Fort University! 🌟 We offer custom essays, term papers, and Harvard HBR business case studies solutions crafted by top-tier experts. Experience tailored solutions, uncompromised quality, and timely delivery. Elevate your academic performance with our trusted and confidential services. Visit Fern Fort University today! #AcademicSuccess #CustomEssays #MBA #CaseStudies

How do you handle tight deadlines for case study solutions?

We are adept at managing tight deadlines by allocating sufficient resources and prioritizing urgent projects. Our team works efficiently without compromising quality, ensuring that even last-minute requests are delivered on time

What if I need revisions or edits after receiving the case study solution?

We offer free revisions to ensure complete client satisfaction. If any adjustments are needed, our team will work closely with you to refine the solution until it meets your expectations.

How do you ensure that the case study solution is plagiarism-free?

All our case study solutions are crafted from scratch and thoroughly checked using advanced plagiarism detection software. We guarantee 100% originality in every solution delivered

How do you handle references and citations in the case study solutions?

We follow strict academic standards for references and citations, ensuring that all sources are properly credited according to the required citation style (APA, MLA, Chicago, etc.).

Hire an expert to write custom solution for HBR Economics case study - Artepharm: Commercialising the Malaria Cure in Africa




Referrences & Bibliography for SWOT Analysis | SWOT Matrix | Strategic Management

1. Andrews, K. R. (1980). The concept of corporate strategy. Harvard Business Review, 61(3), 139-148.

2. Ansoff, H. I. (1957). Strategies for diversification. Harvard Business Review, 35(5), 113-124.

3. Brandenburger, A. M., & Nalebuff, B. J. (1995). The right game: Use game theory to shape strategy. Harvard Business Review, 73(4), 57-71.

4. Christensen, C. M., & Raynor, M. E. (2003). Why hard-nosed executives should care about management theory. Harvard Business Review, 81(9), 66-74.

5. Christensen, C. M., & Raynor, M. E. (2003). The innovator's solution: Creating and sustaining successful growth. Harvard Business Review Press.

6. D'Aveni, R. A. (1994). Hypercompetition: Managing the dynamics of strategic maneuvering. Harvard Business Review Press.

7. Ghemawat, P. (1991). Commitment: The dynamic of strategy. Harvard Business Review, 69(2), 78-91.

8. Ghemawat, P. (2002). Competition and business strategy in historical perspective. Business History Review, 76(1), 37-74.

9. Hamel, G., & Prahalad, C. K. (1990). The core competence of the corporation. Harvard Business Review, 68(3), 79-91.

10. Kaplan, R. S., & Norton, D. P. (1992). The balanced scorecard--measures that drive performance. Harvard Business Review, 70(1), 71-79.

11. Kim, W. C., & Mauborgne, R. (2004). Blue ocean strategy. Harvard Business Review, 82(10), 76-84.

12. Kotter, J. P. (1995). Leading change: Why transformation efforts fail. Harvard Business Review, 73(2), 59-67.

13. Mintzberg, H., Ahlstrand, B., & Lampel, J. (2008). Strategy safari: A guided tour through the wilds of strategic management. Harvard Business Press.

14. Porter, M. E. (1979). How competitive forces shape strategy. Harvard Business Review, 57(2), 137-145.

15. Porter, M. E. (1980). Competitive strategy: Techniques for analyzing industries and competitors. Simon and Schuster.

16. Porter, M. E. (1985). Competitive advantage: Creating and sustaining superior performance. Free Press.

17. Prahalad, C. K., & Hamel, G. (1990). The core competence of the corporation. Harvard Business Review, 68(3), 79-91.

18. Rumelt, R. P. (1979). Evaluation of strategy: Theory and models. Strategic Management Journal, 1(1), 107-126.

19. Rumelt, R. P. (1984). Towards a strategic theory of the firm. Competitive Strategic Management, 556-570.

20. Teece, D. J., Pisano, G., & Shuen, A. (1997). Dynamic capabilities and strategic management. Strategic Management Journal, 18(7), 509-533.